GoodRx Holdings (GDRX) Shares Outstanding (Diluted Average) (2020 - 2026)

GoodRx Holdings has disclosed Shares Outstanding (Diluted Average) across 7 years of filings, most recently posting $341.4 million for Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $341.4 million, down 10.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $341.4 million (down 10.07% YoY), and the FY2025 annual result was $357.0 million, down 8.98% from the prior year.
• Shares Outstanding (Diluted Average) came in at $341.4 million for Q1 2026 at GoodRx Holdings, down from $357.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $423.1 million in Q2 2022 to a low of $341.4 million in Q1 2026.
• The 5-year median for Shares Outstanding (Diluted Average) is $392.9 million (2024), against an average of $392.2 million.
• Across the five-year window, Shares Outstanding (Diluted Average) advanced 0.85% in 2023 and retreated 10.07% in 2026, its largest moves.
• GoodRx Holdings' Shares Outstanding (Diluted Average) stood at $412.9 million in 2022, then decreased by 0.62% to $410.3 million in 2023, then fell by 4.42% to $392.2 million in 2024, then slipped by 8.98% to $357.0 million in 2025, then dropped by 4.36% to $341.4 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $341.4 million (Q1 2026), $357.0 million (Q4 2025), and $361.4 million (Q3 2025), per Business Quant data.